APT Medical Inc.
SSE:688617.SS
392.12 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,065.802 | 1,650.212 | 1,216.018 | 828.688 | 479.436 | 403.964 | 241.773 | 153.174 |
| Cost of Revenue
| 571.959 | 486.14 | 350.166 | 252.843 | 142.127 | 117.891 | 75.485 | 47.768 |
| Gross Profit
| 1,493.843 | 1,164.072 | 865.852 | 575.845 | 337.309 | 286.073 | 166.288 | 105.406 |
| Gross Profit Ratio
| 0.723 | 0.705 | 0.712 | 0.695 | 0.704 | 0.708 | 0.688 | 0.688 |
| Reseach & Development Expenses
| 290.539 | 237.916 | 174.876 | 134.877 | 71.899 | 70.423 | 53.378 | 49.985 |
| General & Administrative Expenses
| 29.225 | 26.385 | 66.546 | 19.251 | 12.378 | 11.268 | 8.047 | 7.104 |
| Selling & Marketing Expenses
| 162.641 | 145.142 | 241.028 | 196.309 | 113.76 | 88.97 | 70.493 | 25.341 |
| SG&A
| 191.867 | 159.904 | 307.574 | 215.56 | 126.138 | 100.238 | 78.54 | 32.446 |
| Other Expenses
| 257.746 | 165.838 | -5.346 | 24.755 | 16.232 | 19.471 | -0.389 | -0.125 |
| Operating Expenses
| 740.152 | 563.657 | 477.105 | 375.192 | 214.27 | 190.132 | 143.645 | 89.629 |
| Operating Income
| 753.691 | 600.415 | 396.988 | 222.502 | 119.446 | 92.094 | 23.601 | 31.119 |
| Operating Income Ratio
| 0.365 | 0.364 | 0.326 | 0.268 | 0.249 | 0.228 | 0.098 | 0.203 |
| Total Other Income Expenses Net
| -7.724 | -4.047 | -1.857 | -0.949 | 1.768 | -0.738 | -0.389 | -0.125 |
| Income Before Tax
| 745.967 | 596.368 | 395.132 | 221.553 | 121.214 | 91.355 | 23.212 | 30.993 |
| Income Before Tax Ratio
| 0.361 | 0.361 | 0.325 | 0.267 | 0.253 | 0.226 | 0.096 | 0.202 |
| Income Tax Expense
| 87.8 | 74.238 | 54.975 | 26.702 | 17.019 | 13.28 | 6.537 | 3.912 |
| Net Income
| 673.152 | 533.924 | 358.02 | 207.921 | 110.776 | 82.575 | 21.512 | 34.483 |
| Net Income Ratio
| 0.326 | 0.324 | 0.294 | 0.251 | 0.231 | 0.204 | 0.089 | 0.225 |
| EPS
| 6.96 | 5.54 | 5.37 | 3.12 | 1.66 | 1.24 | 0.43 | 0.69 |
| EPS Diluted
| 6.92 | 5.46 | 5.37 | 3.12 | 1.66 | 1.24 | 0.43 | 0.69 |
| EBITDA
| 835.412 | 672.402 | 453.02 | 256.205 | 143.219 | 106.295 | 35.472 | 39.58 |
| EBITDA Ratio
| 0.404 | 0.407 | 0.373 | 0.309 | 0.299 | 0.263 | 0.147 | 0.258 |